Beijing Huikang Boyuan Chemical Tech Co.,Ltd has been established since 2005,It is a high-tech enterprise gathering new drug R&D and technology transfer.The company is devoted to the R&D of anti-diabetic new drugs, especially products of gliptins are in the advanced level of domestic industry .

 

The R&D center is located in Fengtai District of Beijing, with total area of laboratory as 1500 square meters.The R&D center will develop 5-10 new products every year and also undertake the registration of new drugs.The company has established the standard quality control mechanism and the perfect quality assurance system, and passed the ISO9000 system certification, submitted 7 liptins products to the USFDA, and has obtained the registration number.

 

Huikang’s R&D technicians have rich experience of technology development. they are familiar with drug GMP management regulations,and have ability to undertake various service such as process research and development, process optimization, product customization from test in the laboratory to process scale-up,they also can solve technical issues such as the cost control,safety risk and "three wastes" treatment which customers may face in production.

 

In line with the operation principle of ‘The customer is supreme, quality is first’.Huikang Boyuan is devoted in innovation and development of anti-diabetic and anti-tumor drugs, gradually building it is own brand,and contribute to the medical industry and human life.Against market competition, Huikang Boyuan sticks to the concept of ‘People -oriented, Scientific and technological innovation’ as driving force and strives to build the core competitiveness of the enterprise and make it a long term and stable development.

 

All products of our company are for scientific research and experimentation only.